Isabelle Riviere, PhD
Disclosures: Consulting Fee-Fate Therapeutics; FloDesign Sonics|Contracted Research-Juno Therapeutics; Fate Therapeutics, Takeda; Atara|Ownership Interest-Juno Therapeutics, Fate Therapeutics, FloDesign Sonics
No Bio Available.